Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vasoactive mediators derived from the endothelium.

R Botting1, J R Vane

  • 1William Harvey Research Institute, St Bartholomew's Hospital Medical College, London, UK.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|November 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The relationship between the penetration of tryptamine and 5-hydroxytryptamine into smooth muscle and the associated contractions.

British journal of pharmacology and chemotherapy·2008
Same author

An analysis of the responses of the isolated portal vein of the rabbit to electrical stimulation and to drugs.

British journal of pharmacology and chemotherapy·2008
Same author

Adventures and excursions in bioassay: the stepping stones to prostacylin.

Bioscience reports·2005
Same author

The mechanism of action of aspirin.

Thrombosis research·2003
Same author

My life and times with enzymes and mediators.

Medical science monitor : international medical journal of experimental and clinical research·2001
Same author

The fight against rheumatism: from willow bark to COX-1 sparing drugs.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2001

Vascular endothelial cells produce prostacyclin and endothelium-derived relaxing factor (EDRF), which prevent blood clots and maintain healthy blood vessels. These mediators, along with endothelin, play crucial roles in cardiovascular health.

Area of Science:

  • Cardiovascular Medicine
  • Endothelial Cell Biology
  • Pharmacology

Background:

  • Vascular endothelial cells (EC) synthesize mediators crucial for maintaining a non-thrombogenic endothelial surface.
  • Prostacyclin, a product of arachidonic acid metabolism, inhibits platelet aggregation and relaxes vascular smooth muscle.
  • Endothelium-derived relaxing factor (EDRF), identified as nitric oxide, also inhibits platelet aggregation and adhesion.

Purpose of the Study:

  • To discuss the roles of prostacyclin, EDRF, and endothelin in vascular health.
  • To explore the synergistic effects of prostacyclin and EDRF in preventing thrombosis.
  • To investigate the paradoxical effects of endothelin in releasing vasodilatory mediators.

Main Methods:

  • Review of scientific literature on endothelial mediators.

Related Experiment Videos

  • Analysis of the biochemical properties and physiological effects of prostacyclin, EDRF, and endothelin.
  • Discussion of clinical implications and therapeutic potential.

    • Main Results:

    • Prostacyclin and EDRF are released together, synergizing to inhibit platelet aggregation.
    • EDRF is nitric oxide, formed from L-arginine.
    • Endothelin, a potent vasoconstrictor, paradoxically stimulates the release of prostacyclin and EDRF.

    Conclusions:

    • Prostacyclin and EDRF constitute an endothelial defense mechanism against thrombotic and chemical insults.
    • Dysfunction of this endothelial barrier is implicated in diseases like hypertension and atherosclerosis.
    • Endothelin's release of vasodilatory mediators suggests a complex role in regulating vascular tone.